Nobuo Cho

1.7k total citations
27 papers, 1.3k citations indexed

About

Nobuo Cho is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nobuo Cho has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Nobuo Cho's work include Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (6 papers) and Hypothalamic control of reproductive hormones (4 papers). Nobuo Cho is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (6 papers) and Hypothalamic control of reproductive hormones (4 papers). Nobuo Cho collaborates with scholars based in Japan, United States and China. Nobuo Cho's co-authors include Mikihiko Naito, Norihito Shibata, Hiroshi Nara, Takayuki Hattori, Nobumichi Ohoka, Osamu Ujikawa, Kenichiro Shimokawa, Tomoya Sameshima, Katsunori Nagai and Yasuhiro Imaeda and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Nobuo Cho

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nobuo Cho Japan	17	1.0k	355	283	211	116	27	1.3k
John Porter United Kingdom	19	548 0.5×	213 0.6×	43 0.2×	241 1.1×	145 1.3×	38	1.1k
Amaury E. Fernández‐Montalván Germany	19	1.0k 1.0×	185 0.5×	137 0.5×	86 0.4×	18 0.2×	38	1.3k
Hariprasad Vankayalapati United States	21	1.5k 1.5×	257 0.7×	58 0.2×	280 1.3×	16 0.1×	61	2.2k
Wen‐Hsing Lin Taiwan	19	569 0.6×	260 0.7×	111 0.4×	212 1.0×	9 0.1×	45	987
Keith Menear United Kingdom	17	1.1k 1.1×	778 2.2×	56 0.2×	393 1.9×	31 0.3×	32	1.6k
David M. Ryckman United States	18	1.3k 1.3×	413 1.2×	75 0.3×	423 2.0×	10 0.1×	31	1.8k
Mikel P. Moyer United States	19	2.1k 2.0×	193 0.5×	267 0.9×	371 1.8×	9 0.1×	28	2.5k
Wan‐Ru Chao Taiwan	18	582 0.6×	133 0.4×	30 0.1×	120 0.6×	50 0.4×	56	846
Mary Pat Beavers United States	17	408 0.4×	63 0.2×	53 0.2×	192 0.9×	51 0.4×	25	729
Kanami Yamazaki Japan	17	892 0.9×	334 0.9×	51 0.2×	238 1.1×	10 0.1×	27	1.4k

Countries citing papers authored by Nobuo Cho

Since Specialization

Citations

This map shows the geographic impact of Nobuo Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Cho more than expected).

Fields of papers citing papers by Nobuo Cho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Cho. The network helps show where Nobuo Cho may publish in the future.

Co-authorship network of co-authors of Nobuo Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Cho. A scholar is included among the top collaborators of Nobuo Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Cho. Nobuo Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cho, Nobuo & Mikihiko Naito. (2022). Synthesis of SNIPERs against BCR-ABL with kinase inhibitors and a method to evaluate their growth inhibitory activity derived from BCR-ABL degradation. Methods in enzymology on CD-ROM/Methods in enzymology. 681. 41–60.

Cho, Nobuo, Yushi Futamura, Takeshi Shimizu, et al.. (2022). New antimalarials identified by a cell-based phenotypic approach: Structure–activity relationships of 2,3,4,9-tetrahydro-1H-β-carboline derivatives possessing a 2-((coumarin-5-yl)oxy)alkanoyl moiety. Bioorganic & Medicinal Chemistry. 66. 116830–116830. 4 indexed citations

Shibata, Norihito, Nobuo Cho, Hiroo Koyama, & Mikihiko Naito. (2022). Development of a degrader against oncogenic fusion protein FGFR3-TACC3. Bioorganic & Medicinal Chemistry Letters. 60. 128584–128584. 5 indexed citations

Nakamura, Shinji, Masahiro Kamaura, Natsuko Nakamura, et al.. (2021). Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducers. Bioorganic & Medicinal Chemistry. 54. 116553–116553. 2 indexed citations

Kurasawa, Osamu, T. Miyazaki, Misaki Homma, et al.. (2020). Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. Journal of Medicinal Chemistry. 63(3). 1084–1104. 16 indexed citations

Ohoka, Nobumichi, Katsunori Nagai, Kenichiro Shimokawa, et al.. (2018). Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation. Journal of Biological Chemistry. 293(18). 6776–6790. 84 indexed citations

Shibata, Norihito, Kenichiro Shimokawa, Katsunori Nagai, et al.. (2018). Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase. Scientific Reports. 8(1). 46 indexed citations

Kurasawa, Osamu, Yuya Oguro, T. Miyazaki, et al.. (2017). Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. Bioorganic & Medicinal Chemistry. 25(7). 2133–2147. 14 indexed citations

Ohoka, Nobumichi, Keiichiro Okuhira, Masahiro Ito, et al.. (2017). In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs). Journal of Biological Chemistry. 292(11). 4556–4570. 193 indexed citations

10.

Kurasawa, Osamu, Misaki Homma, Yuya Oguro, et al.. (2017). 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase. Bioorganic & Medicinal Chemistry. 25(14). 3658–3670. 10 indexed citations

11.

Sakamoto, Kotaro, Yusuke Kamada, Tomoya Sameshima, et al.. (2017). K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology. Biochemical and Biophysical Research Communications. 484(3). 605–611. 88 indexed citations

12.

Shibata, Norihito, Katsunori Nagai, Osamu Ujikawa, et al.. (2017). Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands. Journal of Medicinal Chemistry. 61(2). 543–575. 120 indexed citations

13.

Shimokawa, Kenichiro, Norihito Shibata, Tomoya Sameshima, et al.. (2017). Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation. ACS Medicinal Chemistry Letters. 8(10). 1042–1047. 91 indexed citations

14.

Tanaka, Yuta, Katsuji Aikawa, Goushi Nishida, et al.. (2013). Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins. Journal of Medicinal Chemistry. 56(23). 9635–9645. 91 indexed citations

15.

Cho, Nobuo & Yū Momose. (2008). Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress. Current Topics in Medicinal Chemistry. 8(17). 1483–1507. 68 indexed citations

16.

Imada, Takashi, Nobuo Cho, Toshihiro Imaeda, et al.. (2006). Design, Synthesis, and Structure−Activity Relationships of Thieno[2,3-b]pyridin-4-one Derivatives as a Novel Class of Potent, Orally Active, Non-Peptide Luteinizing Hormone-Releasing Hormone Receptor Antagonists. Journal of Medicinal Chemistry. 49(13). 3809–3825. 14 indexed citations

17.

Hara, Takahito, Hideo Araki, Masami Kusaka, et al.. (2003). Suppression of a Pituitary-Ovarian Axis by Chronic Oral Administration of a Novel Nonpeptide Gonadotropin-Releasing Hormone Antagonist, TAK-013, in Cynomolgus Monkeys. The Journal of Clinical Endocrinology & Metabolism. 88(4). 1697–1704. 26 indexed citations

18.

Sasaki, Satoshi, Nobuo Cho, Masataka Harada, et al.. (2002). Discovery of a Thieno[2,3- d ]pyrimidine-2,4-dione Bearing a p -Methoxyureidophenyl Moiety at the 6-Position: A Highly Potent and Orally Bioavailable Non-Peptide Antagonist for the Human Luteinizing Hormone-Releasing Hormone Receptor. Journal of Medicinal Chemistry. 46(1). 113–124. 140 indexed citations

19.

Sasaki, Satoshi, Toshihiro Imaeda, Yoji Hayase, et al.. (2002). A new class of potent nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists: design and synthesis of 2-phenylimidazo[1,2-a]pyrimidin-5-ones. Bioorganic & Medicinal Chemistry Letters. 12(16). 2073–2077. 19 indexed citations

20.

Cho, Nobuo, Masataka Harada, Toshihiro Imaeda, et al.. (1998). Discovery of a Novel, Potent, and Orally Active Nonpeptide Antagonist of the Human Luteinizing Hormone-Releasing Hormone (LHRH) Receptor. Journal of Medicinal Chemistry. 41(22). 4190–4195. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact